UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Primary pulmonary choriocarcinoma

Radiology and oncology, 2017-03, Vol.51 (1), p.1-7

2017

Volltextzugriff (PDF)

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma

BMC cancer, 2019-04, Vol.19 (1), p.296-296, Article 296

2019

Volltextzugriff (PDF)

The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma

Radiology and oncology, 2023-12, Vol.57 (4), p.493-506

2023

Volltextzugriff (PDF)

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals

Radiology and oncology, 2018-09, Vol.52 (3), p.307-319

2018

Volltextzugriff (PDF)

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

BMC cancer, 2009-04, Vol.9 (1), p.120-120, Article 120

2009

Volltextzugriff (PDF)

Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes

Biomedicines, 2024-02, Vol.12 (3), p.535

2024

Volltextzugriff (PDF)

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

Vaccines (Basel), 2023-05, Vol.11 (6), p.1017

2023

Volltextzugriff (PDF)

Potential of osteopontin in the management of epithelial ovarian cancer

Radiology and oncology, 2019-01, Vol.53 (1), p.105-115

2019

Volltextzugriff (PDF)

Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer

American journal of clinical oncology, 2012-06, Vol.35 (3), p.237-241

2012

Volltextzugriff (PDF)

A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period

Archives of pathology & laboratory medicine (1976), 2024-03, Vol.148 (3), p.299-309

2024

Volltextzugriff (PDF)

Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment

Cancers, 2022-01, Vol.14 (3), p.631

2022

Volltextzugriff (PDF)

Morphological and Immunocytochemical Characterization of Tumor Spheroids in Ascites from High-Grade Serous Carcinoma

Cells (Basel, Switzerland), 2023-09, Vol.12 (19), p.2390

2023

Volltextzugriff (PDF)

Naše izkušnje z zdravilom bevacizumab v primarnem zdravljenju epitelijskega raka jajčnikov

Onkologija, 2020-05, Vol.24 (1)

2020

Volltextzugriff (PDF)

A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer

Cancers, 2023-03, Vol.15 (5), p.1593

2023

Volltextzugriff (PDF)

224 Real-world experience with a first-line olaparib maintenance monotherapy for advanced BRCA mutated ovarian carcinoma

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A305-A305

2024

Volltextzugriff (PDF)

228 A comparison between semiquantitative and digital image analysis for the assessment of tumor-infiltrating lymphocytes in high-grade serous ovarian carcinoma

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A579-A580

2024

Volltextzugriff (PDF)

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing

Cancers, 2022-03, Vol.14 (6), p.1434

2022

Volltextzugriff (PDF)

Cutaneous leukocytoclastic vasculitis in a patient treated with carboplatin for uterine carcinoma

European journal of gynaecological oncology, 2021-02, Vol.42 (1), p.165

2021

Volltextzugriff (PDF)

Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high‐grade serous carcinoma from ascites

Cancer cytopathology, 2023-03, Vol.131 (3), p.188-197

2023

Volltextzugriff (PDF)

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer

Radiology and oncology, 2016-09, Vol.50 (3), p.341-346

2016

Volltextzugriff (PDF)

An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube

Hereditary cancer in clinical practice, 2020-03, Vol.18 (1), p.7-6, Article 7

2020

Volltextzugriff (PDF)

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination

Future oncology (London, England), 2022-07, Vol.18 (23), p.2537-2550

2022

Volltextzugriff (PDF)

Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5545-5545

2021

Volltextzugriff (PDF)

Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6057-6057

2020

Volltextzugriff (PDF)

Izkušnje z zdravilom olaparib pri zdravljenju recidivnega epitelijskega raka jajčnikov z mutacijami v genih BRCA 1 in BRCA 2

Onkologija, 2021-05, Vol.25 (1)

Erik Škof

2021

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Oncology
(19)
Ovarian Cancer
(16)
Patients
(10)
Tumors
(10)
Cancer
(8)
Female
(8)
Humans
(8)
Ascites
(7)
Chemotherapy
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Carcinoma
(5)
Mutation
(5)
Risk Factors
(5)
Aged
(4)
Breast Cancer
(4)
Cancer Therapies
(4)
Health Aspects
(4)
Immunotherapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primary pulmonary choriocarcinoma

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma

The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

Potential of osteopontin in the management of epithelial ovarian cancer

Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer

A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period

Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment

Morphological and Immunocytochemical Characterization of Tumor Spheroids in Ascites from High-Grade Serous Carcinoma

Naše izkušnje z zdravilom bevacizumab v primarnem zdravljenju epitelijskega raka jajčnikov

A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer

224 Real-world experience with a first-line olaparib maintenance monotherapy for advanced BRCA mutated ovarian carcinoma

228 A comparison between semiquantitative and digital image analysis for the assessment of tumor-infiltrating lymphocytes in high-grade serous ovarian carcinoma

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing

Cutaneous leukocytoclastic vasculitis in a patient treated with carboplatin for uterine carcinoma

Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high‐grade serous carcinoma from ascites

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer

An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination

Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis

Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis

Izkušnje z zdravilom olaparib pri zdravljenju recidivnega epitelijskega raka jajčnikov z mutacijami v genih BRCA 1 in BRCA 2

Suchergebnisse filtern